MARKET

ANPC

ANPC

Anpac Bio-Medical Science Co., Ltd.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2470
-0.0006
-0.24%
Closed 18:50 08/10 EDT
OPEN
0.2476
PREV CLOSE
0.2476
HIGH
0.2476
LOW
0.2400
VOLUME
76.81K
TURNOVER
--
52 WEEK HIGH
4.350
52 WEEK LOW
0.2025
MARKET CAP
6.23M
P/E (TTM)
-0.2176
1D
5D
1M
3M
1Y
5Y
AnPac Bio-Medical Science Appoints Yuyang Cui co-Chairman, co-CEO
AnPac Bio-Medical Science Appoints Yuyang Cui co-Chairman, co-CEO
MT Newswires · 3d ago
BRIEF-Anpac Bio-Medical Science Co Ltd - Announces Appointment Of New Directors And Co-Chief Executive Officer
BRIEF-Anpac Bio-Medical Science Co Ltd - Announces Appointment Of New Directors And Co-Chief Executive Officer
Reuters · 5d ago
AnPac Bio appoints Yuyang Cui as co-chief executive officer
AnPac Bio-Medical (NASDAQ:ANPC) <a href="https://see...
Seekingalpha · 5d ago
AnPac Bio-Medical names Co-CEO
On Friday, Chinese biotech AnPac Bio-Medical Science Co., Ltd. (NASDAQ:<a href="https://seekingalpha.com/symbol/ANPC?utm_medium=referral&utm_source=webull.com" title="AnPac Bio-Medical Science Co., Ltd." t...
Seekingalpha · 5d ago
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer
PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announc...
GlobeNewswire · 5d ago
AnPac Bio Approved Written Resolutions of a Majority of the Members Addressing the Removal of Directors and Officers, Re-designation of Officers, and Change of Members of the Committees
PHILADELPHIA, July 18, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announc...
GlobeNewswire · 07/18 22:39
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Benzinga · 06/13 08:28
AnPac Bio regains compliance with requirements to remain listed on Nasdaq capital market
AnPac Bio-Medical Science (NASDAQ:ANPC) rockets 21% premarket on regaining compliance with the requirements to remain listed in The Nasdaq Capital Market, subject to a one-year Mandatory Panel Monitor of the Company’s ongoing
Seekingalpha · 06/10 12:08
More
No Data
Learn about the latest financial forecast of ANPC. Analyze the recent business situations of Anpac Bio-Medical Science Co., Ltd. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ANPC stock price target is 8.00 with a high estimate of 8.00 and a low estimate of 8.00.
High8.00
Average8.00
Low8.00
Current 0.2470
EPS
Actual
Estimate
-0.30-0.22-0.15-0.07
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 11
Institutional Holdings: 772.33K
% Owned: 3.06%
Shares Outstanding: 25.22M
TypeInstitutionsShares
Increased
2
72.28K
New
7
529.55K
Decreased
0
0
Sold Out
2
55.92K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.06%
Pharmaceuticals & Medical Research
+0.92%
Key Executives
Co-Chairman/Co-Chief Executive Officer/Co-Founder/Director
Chang Yu
Co-Chairman/Co-Chief Executive Officer/Director
Aidong Chen
Co-Founder
Herbert Yu
Chief Financial Officer
Jinqiu Tang
Corporate Executive
Weidong Dai
Vice President - Research & Development
Xuedong Du
Director
Feng Guo
Independent Director
Sheng Liu
Independent Director
Ren Luo
Independent Director
Jianhua Shao
Independent Director
Pu Xing
No Data
No Data
About ANPC
AnPac Bio-Medical Science Co., Ltd. is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States.

Webull offers kinds of AnPac Bio-Medical Science Co Ltd - ADR stock information, including NASDAQ:ANPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANPC stock methods without spending real money on the virtual paper trading platform.